ArticleCancer management and research2026

Fatal Disease Progression Driven by Acquired MET Amplification After EGFR-TKI Therapy in EGFR- and RBM10-Mutant Lung Adenocarcinoma.

Jiwon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.